Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSObtusifolin is an anthraquinone that has been found in S. obtusifolia and has diverse biological activities.1,2,3 It prevents IL-1β-induced increases in NF-κB phosphorylation in chondrocytes when used at concentrations ranging from 25 to 200 µM.1 Oral administration of obtusifolin (100 mg/kg) reduces cartilage degradation in a mouse model of osteoarthritis induced by destabilization of the medial meniscus (DMM). Obtusifolin (30 and 90 mg/kg) reduces blood glucose levels, as well as serum malondialdehyde (MDA), nitric oxide (NO), triglyceride, and cholesterol levels, and increases serum superoxide dismutase (SOD), glutathione (GSH), and catalase (CAT) activity in a mouse model of diabetes induced by streptozotocin (STZ; Item No. 13104).2 It also reduces inflammatory pain in mice and neuropathic pain in rats.3
WARNING This product is not for human or veterinary use.
1. Obtusifolin, an anthraquinone extracted from Senna obtusifolia (L.) H.S.Irwin & Barneby, reduces inflammation in a mouse osteoarthritis model. Pharmaceuticals (Basel) 14(3), 249 (2021).
2. Obtusifolin treatment improves hyperlipidemia and hyperglycemia: Possible mechanism involving oxidative stress. Cell Biochem. Biophys. 70(3), 1751-1757 (2014).
3. Anti-